RDA method and kit for rapidly detecting influenza A virus
An influenza A virus and kit technology, applied in the field of molecular biology, can solve the problems of lack of influenza A detection kits, difficulty in obtaining, hindering rapid qualitative detection of influenza, etc., and achieve low detection cost, low mass production cost, The effect of high-precision rapid molecular detection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0081] Example 1 Establishment of a detection method for influenza A virus (FluA) RDA fluorescence detection kit
[0082] (1) Acquisition of recombinant enzyme KX and KY proteins
[0083] The reported recombinant enzyme UvsX has poor stability and is difficult to mass produce and store for a long time. In order to solve this problem, the research and development team used bioinformatics methods to analyze and simulate large quantities of protein structures, and finally found a new recombinant enzyme Enzyme KX and its accessory protein KY.
[0084] In this example, the R&D team extracted the key functional site information in the recombinase structure, such as DNA binding site, ATP hydrolysis site, etc., and mapped it to the three-dimensional structure of the protein to obtain secondary structure information and tertiary structure information , by integrating the functional residues of the primary structure sequence, secondary structure features and tertiary structure spatial ...
Embodiment 2
[0135] Example 2 RDA fluorescence method detection reagent sensitivity test
[0136] The positive control is the pUC57-M1 plasmid containing the M1 gene of influenza A virus (FluA), and the negative control is the empty vector pUC57 plasmid.
[0137] The specific operation is as follows:
[0138] Step 1: Dilute the positive control plasmid to 10^4c, and then dilute to 10^3c, 10^2c, and 10^1c by 10-fold serial dilution.
[0139] Step two, sample processing. Take 5 μL of each concentration of the plasmid in step 1 in an EP tube, and take 5 μL of the negative control in another EP tube, add 20 μL of Buffer A respectively, shake and mix, and let stand at room temperature for 10-15 minutes;
[0140] Step 3, system preparation and testing. Add 25 μL Buffer B to each tube, shake and mix, add 50 μL of the mixed solution to the RDA fluorescence method reaction module, cover the tube cap, shake and centrifuge, and detect immediately; the reaction program is: 39°C for 1 minute, 30 cyc...
Embodiment 3
[0152] Example 3 RDA fluorescence method detection reagent specificity test
[0153] 3 cases of influenza A virus (Influenza A virus, FluA), 1 case of influenza B virus (Influenza B virus, FluB), and 1 case of respiratory syncytial virus (Respiratory Sycytial Virus, RSV) were collected clinically, a total of 5 cases It was verified by fluorescent quantitative PCR that the corresponding virus-positive samples were tested to test the specificity of the kit.
[0154] The specific operation is as follows:
[0155] Step 1. Sample processing. Take 5 μL of each of the above 5 positive samples in EP tubes, and at the same time take 5 μL of the positive control and negative control of the kit in a new EP tube, add 20 μL Buffer A respectively, shake and mix, and let stand at room temperature for 10-15 minutes;
[0156] Step 3, system preparation and testing. Add 25 μL Buffer B to each tube, shake and mix, add 50 μL of the mixed solution to the RDA fluorescence method reaction module,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com